Fig. 1.
Fig. 1. Tetramer staining and IFN-γ production of a T-cell clone and PBMCs. / (A) The left panel shows tetramer staining of a T-cell clone of which most of the T cells are specific for one peptide, revealing the presence of ∼ 87% tetramer+ CD8+ T cells (upper right quadrant). In the right panel, a well of a 96-well nitrocellulose-backed plate containing spots is shown, revealing ∼100 IFN-γ–producing T cells (∼80%) after peptide stimulation of ∼125 cells of the T-cell clone, which comes down to ∼93% IFN-γ–producing tetramer+ T cells. (B) Percentage tetramer staining (3.3%, left panel) and percentage IFN-γ–producing CD8+ T cells after peptide (RAK) stimulation and intracellular IFN-γ staining (1.6%, right panel) of PBMCs of a healthy EBV carrier.

Tetramer staining and IFN-γ production of a T-cell clone and PBMCs.

(A) The left panel shows tetramer staining of a T-cell clone of which most of the T cells are specific for one peptide, revealing the presence of ∼ 87% tetramer+ CD8+ T cells (upper right quadrant). In the right panel, a well of a 96-well nitrocellulose-backed plate containing spots is shown, revealing ∼100 IFN-γ–producing T cells (∼80%) after peptide stimulation of ∼125 cells of the T-cell clone, which comes down to ∼93% IFN-γ–producing tetramer+ T cells. (B) Percentage tetramer staining (3.3%, left panel) and percentage IFN-γ–producing CD8+ T cells after peptide (RAK) stimulation and intracellular IFN-γ staining (1.6%, right panel) of PBMCs of a healthy EBV carrier.

Close Modal

or Create an Account

Close Modal
Close Modal